Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Bacterial Gq Signal Transduction Inhibitor FR900359 Impairs Soil-Associated Nematodes. | J Chem Ecol | 2023 | 37453001 | PubTator, text mining | PubMed |
| Delineation of the phenotypes and genotypes of facial infiltrating lipomatosis associated with PIK3CA mutations. | Orphanet J Rare Dis | 2023 | 37452404 | PubTator, text mining | PubMed |
| Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study. | J Bone Miner Res | 2023 | 37449924 | PubTator, text mining | PubMed |
| Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice. | Int J Mol Sci | 2023 | 37446253 | PubTator, text mining | PubMed |
| Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth. | Cancers (Basel) | 2023 | 37444561 | PubTator, text mining | PubMed |
| Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study. | Cancers (Basel) | 2023 | 37444540 | PubTator, text mining | PubMed |
| Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma. | Clin Oncol (R Coll Radiol) | 2023 | 37433700 | PubTator, text mining | PubMed |
| Clinical and Functional Assessment of Digenicity in Renal Phosphate Wasting. | Nutrients | 2023 | 37432176 | PubTator, text mining | PubMed |
| Mammalian type opsin 5 preferentially activates G14 in Gq-type G proteins triggering intracellular calcium response. | J Biol Chem | 2023 | 37423300 | PubTator, text mining | PubMed |
| Cancer lineage-specific regulation of YAP responsive elements revealed through large-scale functional epigenomic screens. | Nat Commun | 2023 | 37400441 | PubTator, text mining | PubMed |
| Integrative analysis of DNA methylomes reveals novel cell-free biomarkers in lung adenocarcinoma. | Front Genet | 2023 | 37396036 | PubTator, text mining | PubMed |
| GRM1 Gene Fusions as an Alternative Molecular Driver in Blue Nevi and Related Melanomas. | Mod Pathol | 2023 | 37391170 | PubTator, text mining | PubMed |
| Rectal Melanoma: Rare Cancer with Grave Prognosis. | Case Rep Gastroenterol | 2023 | 37383983 | PubTator, text mining | PubMed |
| Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. | Cancer Res Commun | 2023 | 37377898 | PubTator, text mining | PubMed |
| Primary Undifferentiated/Dedifferentiated Cutaneous Melanomas-A Review on Histological, Immunohistochemical, and Molecular Features with Emphasis on Prognosis and Treatment. | Int J Mol Sci | 2023 | 37373134 | PubTator, text mining | PubMed |
| Autosomal Dominant Hypocalcemia Type 1 and Neonatal Focal Seizures. | Children (Basel) | 2023 | 37371242 | PubTator, text mining | PubMed |
| Experimental Models for Rare Melanoma Research-The Niche That Needs to Be Addressed. | Bioengineering (Basel) | 2023 | 37370604 | PubTator, text mining | PubMed |
| Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma. | Pathol Oncol Res | 2023 | 37362244 | PubTator, text mining | PubMed |
| Clinical features and treatment outcomes of progressive uveal melanoma. | Arch Clin Cases | 2023 | 37359088 | PubTator, text mining | PubMed |
| Free fatty acid receptor 1 stimulates cAMP production and gut hormone secretion through Gq-mediated activation of adenylate cyclase 2. | Mol Metab | 2023 | 37348738 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=17